Pyrrolidine-1-carbonitrile has been researched along with Bone Loss, Osteoclastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubin, Y; Falgueyret, JP; Oballa, RM; Okamoto, O; Percival, MD; Prasit, P; Riendeau, D; Rodan, SB; Rydzewski, RM; Wesolowski, G | 1 |
| Barrett, DG; Deaton, DN; Hassell, AM; McFadyen, RB; Miller, AB; Miller, LR; Payne, JA; Shewchuk, LM; Willard, DH; Wright, LL | 1 |
2 other study(ies) available for Pyrrolidine-1-carbonitrile and Bone Loss, Osteoclastic
| Article | Year |
|---|---|
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
Topics: Animals; Bone and Bones; Bone Resorption; Catalytic Domain; Cathepsin K; Cathepsin L; Cathepsins; Cattle; Collagen; Cysteine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Endopeptidases; Glutathione; Humans; In Vitro Techniques; Kinetics; Magnetic Resonance Spectroscopy; Nitriles; Osteoclasts; Pyrrolidines; Rabbits; Rats; Structure-Activity Relationship; Sulfonamides | 2001 |
Acyclic cyanamide-based inhibitors of cathepsin K.
Topics: Animals; Binding Sites; Bone Resorption; Cathepsin B; Cathepsin H; Cathepsin K; Cathepsin L; Cathepsins; Crystallography, X-Ray; Cyanamide; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Models, Molecular; Molecular Structure; Osteogenesis; Protein Binding; Rats; Recombinant Proteins; Structure-Activity Relationship | 2005 |